Literature DB >> 6863939

Resistance to macrophage-mediated killing as a factor influencing the pathogenesis of chronic cutaneous leishmaniasis.

P Scott, D Sacks, A Sher.   

Abstract

Cutaneous leishmaniasis can be either a spontaneously healing or chronic disease, depending upon the strain of parasite and the immunological status of the host. We have investigated parasite factors responsible for the variable pathogenesis observed in leishmanial infections by testing the sensitivity of several leishmanial strains to intracellular killing in lymphokine (LK) activated mouse macrophages. Significant microbicidal activity against Leishmania tropica, a strain which heals in C57BL/6 (B6) mice, was found. In contrast, a strain (Maria) which has previously been shown to induce chronic nonhealing cutaneous lesions in B6 mice was resistant to killing in activated macrophages. This resistance to killing was observed in macrophages activated by LK obtained from either Bacille Calmette-Guérin-, L. tropica, or the Maria strain infected mice. The inability of LK activated macrophages to kill the Maria strain was shown not to be due to parasite induced inhibition of killing mechanisms, since Maria strain infected, LK treated macrophages exhibited tumoricidial activity similar to uninfected macrophages. Furthermore, LK activated macrophages simultaneously infected with the Maria strain and another intracellular pathogen, Toxoplasma gondii, killed Toxoplasma, but not the Maria strain. Temperature was also found to significantly influence the multiplication and killing of Leishmania parasites. As would be expected from their cutaneous nature, L. tropica and Maria strain parasites multiplied better at 35 degrees C than at 37 degrees C. Also consistent with the failure of cutaneous strains to visceralize in immunocompetent mice was the observation that the killing of leishmanial parasites was enhanced at the higher temperature. Thus, the temperature dependent growth capacity and sensitivity to killing of a given leishmanial strain in macrophages may be important factors influencing the pathogenesis of cutaneous leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6863939

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Memory T cells in cutaneous leishmaniasis.

Authors:  Nelson D Glennie; Phillip Scott
Journal:  Cell Immunol       Date:  2016-07-16       Impact factor: 4.868

2.  Novel approach to in vitro drug susceptibility assessment of clinical strains of Leishmania spp.

Authors:  Olga Fernández; Yira Diaz-Toro; Liliana Valderrama; Clemencia Ovalle; Mabel Valderrama; Harry Castillo; Mauricio Perez; Nancy Gore Saravia
Journal:  J Clin Microbiol       Date:  2012-04-18       Impact factor: 5.948

3.  Membrane glycoprotein M-2 protects against Leishmania amazonensis infection.

Authors:  J Champsi; D McMahon-Pratt
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

4.  The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients.

Authors:  G Vitale; G Reina; S Mansueto; R Malta; G Gambino; C Mocciaro; R D'Agostino; M Dieli; E Cillari
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

5.  T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense.

Authors:  J P Sypek; D J Wyler
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

6.  Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis.

Authors:  Hai Qi; Jiaxiang Ji; Nanchaya Wanasen; Lynn Soong
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

7.  Differences in expression and exposure of promastigote and amastigote membrane molecules in Leishmania tropica.

Authors:  M D Sadick; H V Raff
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

8.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria.

Authors:  G S Douvas; D L Looker; A E Vatter; A J Crowle
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

9.  T cell hypo-responsiveness against Leishmania major in MAP kinase phosphatase (MKP) 2 deficient C57BL/6 mice does not alter the healer disease phenotype.

Authors:  Juliane Schroeder; H Adrienne McGachy; Stuart Woods; Robin Plevin; James Alexander
Journal:  PLoS Negl Trop Dis       Date:  2013-02-21

10.  BALB/c mice deficient in CD4 T cell IL-4Rα expression control Leishmania mexicana Load although female but not male mice develop a healer phenotype.

Authors:  Karen J Bryson; Owain R Millington; Thabang Mokgethi; H Adrienne McGachy; Frank Brombacher; James Alexander
Journal:  PLoS Negl Trop Dis       Date:  2011-01-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.